Tesamorelin: GHRH Analog Research Overview

Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH). It belongs to the secretagogue class of research peptides studied for their action on the somatotropic axis. This overview covers what defines tesamorelin structurally, how it differs from related compounds, and the quality-control and handling factors that matter when sourcing it for laboratory work.

Everything below is written for researchers and lab professionals. These products are for research use only and not for human consumption. No dosing, administration, or protocol guidance appears here — by design.

What Tesamorelin Is

Tesamorelin is a stabilized analog of the first 44 amino acids of human GHRH, modified with a trans-3-hexenoyl group at the N-terminus. That modification is the key structural feature. Native GHRH(1-44) degrades quickly in plasma, largely through cleavage by dipeptidyl peptidase-4 (DPP-4). The N-terminal acylation slows that enzymatic breakdown, giving the analog greater stability than the unmodified sequence.

Mechanistically, tesamorelin is studied as a GHRH receptor agonist. It acts on receptors in the anterior pituitary that are associated with the pulsatile release of growth hormone. Because it works upstream at the GHRH receptor rather than mimicking growth hormone directly, it is grouped with GHRH analogs rather than with GH itself or with ghrelin-mimetic secretagogues.

The molecule is a 44-residue peptide with a molecular weight near 5136 Da. That size places it well above short peptides like BPC-157 and has practical consequences for solubility, filtration, and analytical characterization.

Where It Sits Among GHRH and Secretagogue Compounds

Tesamorelin is one of several peptides investigated for their effect on the GH axis, and the distinctions matter when designing comparative experiments.

• GHRH analogs. Tesamorelin and CJC-1295 both act on the GHRH receptor. CJC-1295 is a shorter GHRH(1-29) analog, sometimes studied with or without a drug affinity complex (DAC) modification that extends its half-life.
• Ghrelin-mimetic secretagogues. Ipamorelin acts on the growth hormone secretagogue receptor (GHS-R), a separate pathway. Combination research often pairs a GHRH analog with a ghrelin mimetic — the widely referenced CJC-1295/Ipamorelin blend is a common example — because the two pathways are studied for complementary effects on the somatotropic axis.
• GH fragments. AOD-9604 is a fragment of growth hormone itself, not a releasing-hormone analog, and belongs to a different mechanistic category entirely.

Understanding these categories prevents mislabeling in comparative studies. A GHRH receptor agonist and a GHS-R agonist are not interchangeable, even when downstream readouts overlap.

Purity and Quality Control for Tesamorelin

A 44-residue peptide is harder to synthesize cleanly than a short chain, so analytical documentation carries more weight here. For research-grade tesamorelin, look for these on the Certificate of Analysis:

• HPLC purity. Reversed-phase HPLC is the standard for assessing chromatographic purity. Common thresholds for research peptides are 95%, 98%, and 99%. For a long peptide, deletion sequences and truncation products are the impurities most likely to show up as neighboring peaks, so review the chromatogram, not just the headline number.
• Mass spectrometry. ESI-MS or MALDI-TOF confirms the intact molecular weight matches the expected mass. This is how you verify that the N-terminal acylation and the full 44-residue sequence are present, not a truncated variant.
• Peptide content. The net peptide mass in a vial differs from gross vial weight because of counter-ions (typically acetate or TFA salts) and residual water. Peptide content, often measured by amino acid analysis or UV, tells you how much actual peptide you have.
• Water content. Karl Fischer titration quantifies residual moisture in lyophilized material. Excess water affects both mass accuracy and long-term stability.
• Endotoxin testing. For work involving cell culture or animal models, endotoxin (LAL) data is relevant because bacterial contamination confounds biological readouts.

Peptide Depot provides batch-specific documentation, which matters because purity varies between synthesis lots. A supplier's general spec sheet is not a substitute for testing tied to the exact vial you received.

Storage and Stability

Lyophilized tesamorelin is most stable stored frozen, and colder is better for long-term holding. General practice for research peptides:

• Lyophilized powder: stable for extended periods at -20°C, and longer at -80°C. Short excursions to refrigerator temperature during shipping are typically tolerated for a stable lyophilized product.
• After reconstitution: peptide solutions are far less stable than dry powder. Reconstituted material is generally kept refrigerated and used within a limited window, with freeze-thaw cycles minimized because repeated cycling degrades peptides.
• Light and moisture: keep vials sealed and protected from light. Allow frozen vials to reach room temperature before opening to reduce condensation on the powder.

When reconstituting, bacteriostatic water is a common diluent choice for research handling. Researchers often use a Peptide Calculator to standardize concentrations across experiments and keep records consistent between lots.

How to Read a Tesamorelin Certificate of Analysis

A CoA is only useful if you know which lines carry weight. Here is a practical reading order for a long GHRH analog like tesamorelin.

1. Confirm the identity first. Check the mass spec result against the theoretical monoisotopic or average mass (~5136 Da). If the observed mass is off by a residue's worth of mass, you may have a deletion sequence — investigate before proceeding.
2. Read the HPLC number and the trace together. A stated 98% purity means little without the chromatogram. Look for a single dominant peak. Clusters of small peaks near the main peak in a long peptide often indicate closely related synthesis byproducts.
3. Separate peptide content from purity. Purity is the fraction of peptide that is the correct sequence. Content is how much peptide versus salt and water is in the vial. Both affect how you calculate working concentrations. Confusing them is a common source of error.
4. Check the water content. High residual moisture from Karl Fischer analysis signals a vial that may be less stable over time and can skew mass-based calculations.
5. Match the lot number. The CoA lot must match the vial label. Batch-specific testing is the entire point — a document for a different lot tells you nothing about what is in your hands.

If any of these fields is missing, ask the supplier before you build an experiment around the material.

Frequently Asked Questions

What class of peptide is tesamorelin?

Tesamorelin is a GHRH (growth hormone-releasing hormone) analog. It is a stabilized synthetic version of GHRH(1-44) studied as a GHRH receptor agonist, placing it in the secretagogue category of research peptides.

How is tesamorelin different from CJC-1295?

Both are GHRH analogs that act on the GHRH receptor, but they differ structurally. Tesamorelin is a modified full-length GHRH(1-44) sequence with an N-terminal acylation, while CJC-1295 is based on the shorter GHRH(1-29) sequence, sometimes with a DAC modification to extend its half-life.

How should tesamorelin be stored in a lab?

Lyophilized tesamorelin is best stored frozen at -20°C for the near term and -80°C for longer holding. After reconstitution it is much less stable and is generally kept refrigerated, with freeze-thaw cycles minimized. Keep vials sealed and protected from light.

What purity should research-grade tesamorelin have?

Common HPLC purity thresholds for research peptides are 95%, 98%, and 99%. Because tesamorelin is a long 44-residue peptide, review the full HPLC chromatogram and mass spectrometry data, not just the headline purity percentage.

Is tesamorelin sold by Peptide Depot for human use?

No. Tesamorelin and all peptides from Peptide Depot are supplied strictly for laboratory research use only and are not for human consumption. They are intended for qualified researchers and lab professionals.

The Bottom Line

Tesamorelin is a stabilized GHRH(1-44) analog studied as a GHRH receptor agonist within the growth hormone axis. Its length makes analytical characterization especially important — mass spec identity, HPLC purity with a clean chromatogram, peptide content, and Karl Fischer water data all matter. Pair that documentation with proper frozen storage and batch-specific testing.

Canadian researchers sourcing tesamorelin should confirm lot-matched documentation before designing experiments. For handling questions, the Peptide Depot FAQ covers common sourcing and storage points. All products remain for research use only and not for human consumption.